CXCR4 Imaging: Based on a high-affinity CXCR4 ligand, an imaging agent for CXCR4-positive tumors was developed through structure–activity relationship studies. The best compound was evaluated in vivo and shown to have excellent properties as a positron emission tomography (PET) tracer.
No takes yet. Share an insight, caveat, or question.
Demmer et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: